First Light Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-645,848
Closed -$60M 80
2021
Q4
$60M Sell
645,848
-314
-0% -$20.7K 4.3% 8
2021
Q3
$38.5M Buy
646,162
+29,038
+5% +$1.72M 2.54% 15
2021
Q2
$42.1M Buy
617,124
+270,850
+78% +$17.7M 2.53% 13
2021
Q1
$24M Buy
346,274
+24,307
+8% +$1.87M 1.59% 26
2020
Q4
$24.7M Buy
321,967
+56,628
+21% +$4.24M 1.83% 23
2020
Q3
$19.8M Buy
265,339
+249
+0.1% +$16.6K 2.03% 18
2020
Q2
$16.7M Buy
265,090
+171,761
+184% +$9.45M 1.94% 21
2020
Q1
$3.92M Sell
93,329
-92,399
-50% -$4.24M 0.67% 36
2019
Q4
$8.44M Sell
185,728
-5,110
-3% -$242K 1.08% 27
2019
Q3
$8.73M Buy
190,838
+146,134
+327% +$8.21M 1.32% 25
2019
Q2
$2.62M Buy
+44,704
New +$2.31M 0.36% 44

First Light Asset Management's ARNA Position: Q1 2022 in Review

First Light Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 645,848 shares — an estimated $60M sold.

First Light Asset Management first reported a position in ARNA in Q2 2019 and held it in 11 quarters. The position peaked at $60M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • First Light Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • First Light Asset Management sold 645,848 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $60M.
  • First Light Asset Management first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 11 quarters.
  • First Light Asset Management's Arena Pharmaceuticals Inc position peaked at $60M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on First Light Asset Management's 13F filing for Q1 2022, filed 13 May 2022.